Journal
ANNALS OF MEDICINE
Volume 32, Issue 1, Pages 6-14Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/07853890008995904
Keywords
age-related cognitive decline; Alzheimer's disease; biological markers; brain imaging; genetic markers; hippocampal atrophy; magnetic resonance imaging; mild cognitive impairment; positron emission tomography; single-photon emission computed tomography
Categories
Ask authors/readers for more resources
With the promising development of effective treatment, significant improvement in the very early diagnosis of Alzheimer's disease (AD) is required. There is vast agreement that a decline in memory, especially in verbal episodic memory, is the earliest and perhaps the most sensitive sign of incipient AD at the preclinical stage. However, this review offers evidence that impairment in episodic memory can be observed in normal elderly people as well as in aged subjects with mild cognitive impairment (MCI), a large proportion of whom will, however, not convert to dementia. Quantitative measurement of atrophy and brain activation in the hippocampal-parahippocampal formation by using structural and functional magnetic resonance imaging may help to distinguish the MCI decliners from the nondecliners. Cerebrospinal fluid levels of tau protein and A beta(1-42) peptide, together with the presence of an apolipoprotein (apo)E epsilon 4 allele may also increase our confidence in the early positive diagnosis of AD. This review concludes, however, that while adequate for constituting groups of patients in a research perspective, the extensive diagnostic procedure based on specific cognitive testing, neuroimaging and biological investigations is still out of reach for the practitioner.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available